C4 Therapeutics, Inc.
CCCC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662579
No open-market purchases or sales by C4 Therapeutics, Inc. insiders were filed in the last 90 days; 147 institutions reported holding it in 13F filings for Q2 2026, worth $547.6M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in C4 Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 125
- +6 vs. Q4 2021
- Shares held
- 37.3M
- +1.43M (+4.0%) vs. Q4 2021
- Total value
- $904.8M
- −$250.1M (−21.7%) vs. Q4 2021
- New holders
- 29
- 47 more added
- Sold out
- 23
- 32 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CCCC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 147 | $547.6M |
| Q1 2026 | 123 | $221.3M |
| Q4 2025 | 101 | $152.5M |
| Q3 2025 | 97 | $116.6M |
| Q2 2025 | 102 | $78.2M |
| Q1 2025 | 115 | $102.6M |
| Q4 2024 | 113 | $231.8M |
| Q3 2024 | 118 | $365.9M |
| Q2 2024 | 115 | $281.3M |
| Q1 2024 | 106 | $475.6M |
| Q4 2023 | 92 | $265.6M |
| Q3 2023 | 84 | $64.5M |
| Q2 2023 | 100 | $94.1M |
| Q1 2023 | 121 | $117.5M |
| Q4 2022 | 117 | $231.4M |
| Q3 2022 | 114 | $345.9M |
| Q2 2022 | 113 | $297.2M |
| Q1 2022 | 125 | $904.8M |
| Q4 2021 | 119 | $1.15B |
| Q3 2021 | 113 | $1.54B |
| Q2 2021 | 107 | $1.21B |
| Q1 2021 | 83 | $926.8M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding C4 Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Amalgamated Financial Corp. | 6,290 | $153.0K | 0.00% | +6,290 | New |
| Victory Capital Management Inc | 16,409 | $141.0K | 0.00% | −121−0.7% | Reduced |
| STRS Ohio | 5,600 | $135.0K | 0.00% | 00.0% | Unchanged |
| Virtus ETF Advisers LLC | 5,275 | $128.0K | 0.06% | −314−5.6% | Reduced |
| Group One Trading, L.P. | 4,500 | $109.0K | 0.00% | +4,000+800.0% | Added |
| Point72 Hong Kong Ltd | 3,815 | $93.0K | 0.01% | +1,804+89.7% | Added |
| Lazard Asset Management LLC | 3,834 | $93.0K | 0.00% | +3,834 | New |
| BIT Capital GmbH | 3,800 | $92.2K | 0.01% | +3,800 | New |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 3,421 | $83.0K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 2,962 | $72.0K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 2,583 | $62.7K | 0.00% | −7,792−75.1% | Reduced |
| Royal Bank of Canada | 2,456 | $60.0K | 0.00% | −9,019−78.6% | Reduced |
| Tortoise Investment Management, LLC | 1,842 | $45.0K | 0.01% | +1,842 | New |
| Caption Management, LLC | 1,800 | $43.0K | 0.00% | +1,800 | New |
| Dark Forest Capital Management LP | 573 | $13.0K | 0.00% | +573 | New |
| Nisa Investment Advisors, LLC | 490 | $12.0K | 0.00% | −1,130−69.8% | Reduced |
| Leonteq Securities AG | 480 | $11.6K | 0.00% | 00.0% | Unchanged |
| Piscataqua Savings Bank | 401 | $10.0K | 0.01% | 00.0% | Unchanged |
| Endurance Wealth Management, Inc. | 350 | $8.00K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 142 | $3.00K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 118 | $3.00K | 0.00% | +118 | New |
| Lindbrook Capital, LLC | 83 | $2.00K | 0.00% | +83 | New |
| Quadrant Capital Group LLC | 22 | $1.00K | 0.00% | +22 | New |
| Covestor Ltd | 9 | $0 | 0.00% | −2−18.2% | Reduced |
| First Horizon Advisors, Inc. | 15 | $0 | 0.00% | +15 | New |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −1,377,569−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −996,477−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −581,028−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −81,720−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −60,903−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −54,100−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −41,897−100.0% | Sold out |
| Goldstream Capital Management Ltd | 0 | $0 | 0.00% | −36,193−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −31,300−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −27,001−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −25,735−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −21,283−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −16,109−100.0% | Sold out |
| EMC Capital Management | 0 | $0 | 0.00% | −10,619−100.0% | Sold out |
| Dymon Asia Capital (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −8,250−100.0% | Sold out |
| Handelsbanken Fonder AB | 0 | $0 | 0.00% | −8,200−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −7,149−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −6,570−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −1,700−100.0% | Sold out |
| Migdal Insurance & Financial Holdings Ltd. | 0 | $0 | 0.00% | −605−100.0% | Sold out |
| Cambridge Trust Co | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Ford Financial Group, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |